NHLBI Awards $45 Million to Fight Vascular Disease

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, recently awarded twelve five-year grants totaling about $45 million for research related to Peripheral Arterial Disease (PAD). This is a monumental step toward finding treatments and technologies to improve the care and management of this disease. The purpose of awarding these grants according to the NHLBI was "to develop improved therapeutic and preventive approaches for atherosclerotic arterial diseases of the peripheral vasculature" through clinical research studies. The results of these studies will provide new insights for better clinical management of the disease, and improved strategies for diagnosis, therapy and prevention of PAD. This is exciting and offers hope for all affected by PAD. We are grateful for NHLBI's focus on PAD and look forward to the results of these important studies.